In Brief Dana-Farber Cancer Institute forms three-year immuno-oncology lung cancer collaboration with Johnson & Johnson and Janssen Biotech July 18, 2014Vol.40 No.29
Capitol Hill Advocates Lobby Congress to Close Medicare Loophole for Colonoscopy Coverage July 18, 2014Vol.40 No.29By Tessa Vellek
DePinho’s Handling of Tenure Dispute Triggers Formal Investigation by AAUP July 18, 2014Vol.40 No.29By Matthew Bin Han Ong
Drugs & Targets Breakthrough Therapy designation granted to blinatumomab in Ph- ALL July 11, 2014Vol.40 No.28
Drugs & Targets European Commission approves Halaven for metastatic breast cancer July 11, 2014Vol.40 No.28
Drugs & Targets Mylan launches generic Carboplatin Injection in multi-dose vials July 11, 2014Vol.40 No.28
In Brief Steven Bangert named CEO of the Year by the American Cancer Society July 11, 2014Vol.40 No.28